Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: A case report

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 11, 2009, Pages 858-860

  Vlahovic, Aleksandar ^a   Simic, Radoje ^a   Djokic, Dragomir ^b   Ceran, Candemir ^c  

^a Division of Pediatric Surgery   (Serbia)

^b Institute of Forestry   (Serbia)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cyclophosphamide; Diffuse neonatal hemangiomatosis; Hepatic hemangioma

Indexed keywords

AMINOPHYLLINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIGITALIS; DIGOXIN; DIURETIC AGENT; FUROSEMIDE; MESNA; SALBUTAMOL; SPIRONOLACTONE;

ARTICLE; BRONCHOSCOPY; CARDIOMEGALY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; CORTICOSTEROID THERAPY; DRUG SUBSTITUTION; FACE; FOLLOW UP; HEART FAILURE; HEMANGIOMATOSIS; HUMAN; INFANT; KIDNEY HEMANGIOMA; LARYNGOSCOPY; LIMB; LIVER HEMANGIOMA; LIVER SIZE; MALE; MULTIPLE CYCLE TREATMENT; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA EFFUSION; PRIORITY JOURNAL; SCALP; SKIN HEMANGIOMA; THORAX RADIOGRAPHY; THYROID FUNCTION; TRACHEOBRONCHIAL TREE; TREATMENT OUTCOME; TREATMENT RESPONSE; TRUNK; TUMOR LOCALIZATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; HEMANGIOMA; HUMANS; INFANT; MALE; MESNA; ORGAN SPECIFICITY; PROTECTIVE AGENTS; REMISSION INDUCTION;

EID: 74249103542     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b536ad     Document Type: Article

References (17)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69: 412-422.
2. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol. 2004;50:875-882.
3. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341:173-181.
4. Fishman SJ, Mulliken JB. Vascular anomalies. Pediatr Clin North Am. 1998;45:1455-1477.
5. Daitchi M, Simic R, Vlahovic A, et al. Tessier 30 median mandibular cleft associated with lower lip hemangioma. Plast Reconstr Surg. 2003;112:935-936.
6. Ho Vwg Krol A, Bhargava R, Osiovich H. Diffuse neonatal haemangiomatosis. J Paediatr Child Health. 2000;36:286-289.
7. Holden KR, Alexander F. Diffuse neonatal hemangiomatosis. Pediatrics. 1970;46:411-421.
8. Leproire E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr. 1999;89:93-97.
9. Hurwitz SA, Hurvitz CH, Sloninsky L. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol. 2000; 22:527-532.
10. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med. 2000;343:185-189.
11. Encholras O, Riche MC, Merland JJ, et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990;85:491-498.
12. Ezekowitz RAB, Phil CBD, Mulliken JB, et al. Interferon alfa 2a therapy for the life-threatening hemangiomas in infancy. N Eng J Med. 1992;326:1456-1463.
13. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr. 1996;129:346-354.
14. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998;132:1456-1463.
15. Christison-Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007; 42:62-68.
16. Gottschling S, Schneider G, Meyer S, et al. Two infants with lifethreatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer. 2006;46: 239-242.
17. Castro R, Meek R, Bean C, et al. Successful treatment of a giant cavernous hemangioma with oral cyclophosphamide (Cytoxan) in an infant. Del Med J. 1992;64:745-749.